Skip to content

BioLife Solutions BLFS Net debt / EBITDA

Net debt / EBITDA at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.2×-0.2×
Danaher logo
DanaherDHR
1.9×-0.2×
Azenta logo
AzentaAZTA
-42×-10.1×
TEC
Bio-TechneTECH
0.0×
Revvity logo
RevvityRVTY
+1.2×
Charles River Laboratories logo
Charles River LaboratoriesCRL
4.1×+0.6×

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.38B+34.4%
Enterprise value$1.37B+35.0%
P/S13.8×+1.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

Based on the most recent quarter.

The official record: BioLife Solutions’s 10-Q, filed May 8, 2025, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's net debt / EBITDA?
BioLife Solutions (BLFS) reported net debt / EBITDA of -18.3× in Q1 2025.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.